Government patent use (United States) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Government patent use (United States)" in English language version.

refsWebsite

Global rank English rank

4nih.gov

4^th place

3doi.org

2^nd place

2web.archive.org

1^st place

2findlaw.com

1,478^th place

868^th place

1gpo.gov

1,360^th place

845^th place

1cornell.edu

332^nd place

246^th place

1yale.edu

565^th place

460^th place

1keionline.org

low place

1mwe.com

low place

1patentdocs.org

low place

1washingtonpost.com

34^th place

27^th place

1bloomberg.com

99^th place

77^th place

1pppmag.com

low place

bloomberg.com

Armstrong, Drew (21 March 2014). "Gilead's $84,000 Treatment Questioned by U.S. Lawmakers". Bloomberg. Retrieved 27 October 2015.

cornell.edu

law.cornell.edu

"United States Code, Supplement 5, Title 28 - Judiciary and Judicial Procedure" (PDF). 2006. Section 1498. Patent and Copyright cases. Title 28, Judiciary and Judicial Procedure, Part IV. Jurisdiction and Venue. Chapter 91 United States Court of Federal Claims.

doi.org

Kapczynski, Amy; Kesselheim, Aaron S. (May 10, 2016). "'Government Patent Use': A Legal Approach To Reducing Drug Spending" (PDF). Health Affairs. 35 (5791): 791–797. doi:10.1377/hlthaff.2015.1120. PMID 27140984. Archived from the original (PDF) on September 1, 2017. Retrieved June 4, 2017.
Hill, A; Simmons, B; Gotham, D; Fortunak, J (1 January 2016). "Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C." Journal of Virus Eradication. 2 (1): 28–31. doi:10.1016/S2055-6640(20)30691-9. PMC 4946692. PMID 27482432.
Brennan, T.; Shrank W. (2014). "New expensive treatments for hepatitis C infection". JAMA. 312 (6): 593–594. doi:10.1001/jama.2014.8897. PMID 25038617.

findlaw.com

caselaw.findlaw.com

Gargoyles, Inc., and Pro-Tec, Inc., v. United States, 113 F.3d 1572 (Fed. Cir. 1997).
"Advanced Software Design Corp. v. Federal Reserve Bank of St. Louis 583 F.3d 1371". Federal Circuit Court. 2009.

gpo.gov

"United States Code, Supplement 5, Title 28 - Judiciary and Judicial Procedure" (PDF). 2006. Section 1498. Patent and Copyright cases. Title 28, Judiciary and Judicial Procedure, Part IV. Jurisdiction and Venue. Chapter 91 United States Court of Federal Claims.

keionline.org

Love, James (July 18, 2014). "Non-voluntary use of patents for drugs to treat the hepatitis C virus in the United States: mechanisms available to the federal government, state governments and private actors" (PDF). KEI Policy Brief 2014:1. Retrieved July 4, 2017.

mwe.com

Yoon, Rita J. (September 2016). "Army Ammunition Goes Green and Infringement Free". Patents Claim Construction.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kapczynski, Amy; Kesselheim, Aaron S. (May 10, 2016). "'Government Patent Use': A Legal Approach To Reducing Drug Spending" (PDF). Health Affairs. 35 (5791): 791–797. doi:10.1377/hlthaff.2015.1120. PMID 27140984. Archived from the original (PDF) on September 1, 2017. Retrieved June 4, 2017.
Hill, A; Simmons, B; Gotham, D; Fortunak, J (1 January 2016). "Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C." Journal of Virus Eradication. 2 (1): 28–31. doi:10.1016/S2055-6640(20)30691-9. PMC 4946692. PMID 27482432.
Brennan, T.; Shrank W. (2014). "New expensive treatments for hepatitis C infection". JAMA. 312 (6): 593–594. doi:10.1001/jama.2014.8897. PMID 25038617.

ncbi.nlm.nih.gov

Hill, A; Simmons, B; Gotham, D; Fortunak, J (1 January 2016). "Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C." Journal of Virus Eradication. 2 (1): 28–31. doi:10.1016/S2055-6640(20)30691-9. PMC 4946692. PMID 27482432.

patentdocs.org

Zuhn, Donald (May 18, 2015). "Senator Asks Department of Veteran Affairs to Break Patents on Hepatitis C Drugs". Patent Docs. Retrieved July 4, 2017.

pppmag.com

Lucio, Steven (February 2015). "The Increasing Impact of High-Cost Specialty Therapies". Pharmacy Purchasing & Products Magazine. Archived from the original on 8 December 2015. Retrieved 4 December 2015.

washingtonpost.com

Johnson, Carolyn Y. (July 3, 2017). "Louisiana considers radical step to counter high drug prices: Federal intervention". Baton Rouge, Louisiana. Retrieved July 4, 2017.

web.archive.org

Kapczynski, Amy; Kesselheim, Aaron S. (May 10, 2016). "'Government Patent Use': A Legal Approach To Reducing Drug Spending" (PDF). Health Affairs. 35 (5791): 791–797. doi:10.1377/hlthaff.2015.1120. PMID 27140984. Archived from the original (PDF) on September 1, 2017. Retrieved June 4, 2017.
Lucio, Steven (February 2015). "The Increasing Impact of High-Cost Specialty Therapies". Pharmacy Purchasing & Products Magazine. Archived from the original on 8 December 2015. Retrieved 4 December 2015.

yale.edu

law.yale.edu

Kapczynski, Amy; Kesselheim, Aaron S. (May 10, 2016). "'Government Patent Use': A Legal Approach To Reducing Drug Spending" (PDF). Health Affairs. 35 (5791): 791–797. doi:10.1377/hlthaff.2015.1120. PMID 27140984. Archived from the original (PDF) on September 1, 2017. Retrieved June 4, 2017.